Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1400
-0.0050 (-3.45%)
May 22, 2026, 12:05 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 27.21 million as of May 22, 2026. Its market cap has increased by 19.20% in one year.
Market Cap
27.21M
Enterprise Value
29.77M
Revenue
179.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 27.21M, an increase of 298.70%. That is a compound annual growth rate of 7.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 27.21M | 15.51% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vector Science and Therapeutics | 165.52M |
| Cannabix Technologies | 78.62M |
| Theralase Technologies | 66.20M |
| Perimeter Medical Imaging AI | 46.96M |
| Cheelcare | 34.61M |
| Conavi Medical | 28.98M |
| Aurora Spine | 18.98M |
| Frequency Exchange | 18.59M |